Why the study?
What are the short-term (90-minute) and weekly biological variations of hs-cTnT and hs-cTnI in hemodialysis patients compared to healthy controls?
What are the short-term (90-minute) and weekly biological variations of hs-cTnT and hs-cTnI in hemodialysis patients compared to healthy controls?
The biological variation of hs-cTnT is lower than that of hs-cTnI in both hemodialysis patients and healthy controls, suggesting a lower false-positive rate for MI diagnosis when using a 20%-50% change criteria with hs-cTnT.
Answers are grounded in this paper and cite their sources.
Lower hs-cTnT variation may reduce false positives in HD patients; extends variation data to this group but leaves optimal thresholds open.
BACKGROUND: Myocardial infarction (MI) is diagnosed by the finding of a single cardiac troponin value above the 99th percentile and a significant time-dependent change in cardiac troponin concentration. The aim of this study was to determine the 90-min and weekly biological variations, the reference change value (RCV), and the index of individuality (II) of high-sensitivity cardiac troponin T (hs-cTnT) (Roche Diagnostics) and hs-cTnI (Abbott Diagnostics) in patients receiving hemodialysis (HD) and in healthy individuals. METHOD: Blood samples were collected from 19 HD patients (on an HD-free day) and 20 healthy individuals at 90-min intervals over a 6-h period (between 08:30 and 14:30) and before the midweek HD treatment for 10 weeks. The within-person variation (CVi), between-person variation, RCV, and II were calculated. RESULTS: During the 6-h sampling period, the concentrations of hs-cTnT (both groups) and hs-cTnI (HD patients only) decreased on average by 0.8% to 1.7% per hour, respectively. These declining trends were included in the calculation of a 90-min asymmetric RCV: -8%/+5% in HD patients (hs-cTnT), -18%/+21% in HD patients (hs-cTnI), -27%/+29% in healthy individuals (hs-cTnT), and -39%/+64% in healthy individuals (hs-cTnI). The II was low in both groups for both assays. The weekly CVi values were approximately 8% (hs-cTnT) and 15% (hs-cTnI) in both groups. CONCLUSIONS: When using a cardiac troponin change of 20%-50% to diagnose an MI, the false-positive rate is likely to be lower for the hs-cTnT assay than for the hs-cTnI assay. The low II suggests that use of a diagnostic cutoff value can be omitted.
No takes yet. Share an insight, caveat, or question.
Aakre et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: